共 7 条
[1]
Important and emerging -lactamase-mediated resistances in hospital -based pathogens: the AmpC enzymes. Jones R N. Diagnostic Microbiology and Infectious Disease . 1998
[2]
Studies on relationship between membrane proteins and antimicrobial resistance in clinical isolate of Pseudomonas aeruginosa. Cheng Q M,Wang Y G,Gao M Y. Chinese Journal of Antibiotics . 1997
[3]
The inducibility of AmpC enzyme of Enterobacter cloacae and its susceptibility to enzyme inhibitor. Zhang Y L,Li J T,Zhao M W. National Medical Journal of China . 2001
[4]
The detection of derepressed AmpC enzyme and extended-spectrum -lactamases in Enterobacter cloacae. Wu W Y,Chen M J,Wang H. Chinese Journal of Clinical Pharmacology . 2001
[5]
Occurrence and detection of AmpC -lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veteranis medical center. Coudron P E,Moland E S,Thomoson K S. Journal of Clinical Microbiology . 2000
[6]
Characterization of the plasmid -lactamase CMY-2, which is responsible for cephamycin resistance. Bauernfeinal,Stemplinger I,Jungwirth R,et al. Antimicrobial Agents and Chemotherapy . 1996
[7]
Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. Cao V T,Arlet G,Ericsson B I,et al. Journal of Antimicrobial Chemotherapy . 2000